4.7 Review

The regulatory role of autophagy-related miRNAs in lung cancer drug resistance

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy

Yang Zhou et al.

Summary: The study found that miR-133a expression was decreased in cisplatin-resistant ovarian cancer cells, and overexpression of miR-133a reduced cisplatin resistance. MiR-133a binds to the 3'UTR of YES1 and downregulates its expression. YES1 expression was upregulated in cisplatin-resistant ovarian cancer tissue, and miR-133a downregulated YES1 to inhibit cell autophagy and reduce cisplatin resistance.

CANCER CELL INTERNATIONAL (2022)

Article Reproductive Biology

MicroRNA-20a-5p inhibits the autophagy and cisplatin resistance in ovarian cancer via regulating DNMT3B-mediated DNA methylation of RBP1

Hui Li et al.

Summary: In this study, researchers investigated the role of miR-20a-5p in modulating autophagy and cisplatin resistance in ovarian cancer. They found that miR-20a-5p suppresses malignant phenotypes and autophagy in cisplatin-resistant ovarian cancer cells. Furthermore, they demonstrated that DNMT3B mediates DNA methylation of RBP1, impairing its promoting effects on carcinogenesis and autophagy in ovarian cancer. Overall, the study highlights the importance of miR-20a-5p in the regulation of autophagy and cisplatin resistance in ovarian cancer.

REPRODUCTIVE TOXICOLOGY (2022)

Review Oncology

A Promising Treatment Strategy for Lung Cancer: A Combination of Radiotherapy and Immunotherapy

Yuhei Miyasaka et al.

Summary: Lung cancer is a leading cause of cancer-related deaths worldwide. Radiotherapy has achieved significant technical advances and is widely used in the management of lung cancer. The anti-tumor effect of radiotherapy is mainly caused by DNA damage in cancer cells. Additionally, radiotherapy induces anti-tumor immune responses, but also suppresses the immune system. Combining radiotherapy with immunotherapy, particularly immune checkpoint inhibitors, shows promise in overcoming immunosuppressive conditions in lung cancer patients. Particle therapy using protons and carbon ions in combination with immunotherapy is also a promising treatment strategy according to evidence outlined in this review.

CANCERS (2022)

Article Oncology

Long noncoding RNA DANCR confers cytarabine resistance in acute myeloid leukemia by activating autophagy via the miR-874-3P/ATG16L1 axis

Hao Zhang et al.

Summary: This study identifies DANCR as a positive regulator of Ara-C resistance in human AML cells, suggesting that this lncRNA may serve as a potential target for overcoming Ara-C resistance in AML chemotherapy by promoting MIR-874-3P/ATG16L1 axis-regulated autophagy.

MOLECULAR ONCOLOGY (2021)

Review Genetics & Heredity

The role of long non-codingRNAsin drug resistance of cancer

He-da Zhang et al.

Summary: Long non-coding RNAs (lncRNAs) are critical genomic regulators involved in genomic imprinting regulation, histone modification, gene expression regulation, and tumor initiation and progression. They are also associated with drug resistance in various types of cancer.

CLINICAL GENETICS (2021)

Article Cell Biology

Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway

Minghe Lv et al.

Summary: The combination treatment of AKBA and cisplatin enhances the sensitivity of NSCLC cells to cisplatin by regulating cell cycle, inducing apoptosis, and suppressing autophagy.

CELL BIOLOGY AND TOXICOLOGY (2021)

Article Biochemistry & Molecular Biology

Nuclear miR-30b-5p suppresses TFEB-mediated lysosomal biogenesis and autophagy

Huijie Guo et al.

Summary: The study revealed that miR-30b-5p can inhibit TFEB-dependent gene transcription by binding to CLEAR elements in the nucleus, thus affecting lysosomal biogenesis and autophagy. Knocking out miR-30b-5p increases TFEB transactivation, leading to increased expression of autophagy and lysosomal biogenesis-related genes.

CELL DEATH AND DIFFERENTIATION (2021)

Article Cell Biology

Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration

Ali Mohammadi et al.

Summary: Low miR-330 expression in lung cancer predicts poor prognosis, but stable restoration of miR-330 expression can reduce cell viability, increase apoptotic cells, induce G2/M cell cycle arrest, and inhibit cell migration.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Review Biotechnology & Applied Microbiology

Mechanisms of drug resistance mediated by long non-coding RNAs in non-small-cell lung cancer

Manuela La Montagna et al.

Summary: Non-small-cell lung cancer (NSCLC) is the most prevalent form of lung cancer with a poor five-year survival rate of 15%. While chemotherapy and targeted therapies have improved patient prognosis, some patients still relapse due to drug resistance. Recent research has focused on long non-coding RNAs (lncRNAs) and their role in regulating tumor growth and drug response mechanisms in NSCLC.

CANCER GENE THERAPY (2021)

Article Cell Biology

Esomeprazole overcomes paclitaxel-resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells

Zhaoshi Bai et al.

Summary: The study found that esomeprazole could enhance the efficacy of paclitaxel in NSCLC cells resistant to the drug by reducing intracellular pH, promoting microtubule polymerization, and increasing apoptosis. This offers a promising new strategy for overcoming paclitaxel resistance in NSCLC treatment.

CELL BIOLOGY INTERNATIONAL (2021)

Article Medicine, Research & Experimental

MicroRNA-130b functions as an oncogene and is a predictive marker of poor prognosis in lung adenocarcinoma

Yeseul Kim et al.

Summary: This study found that high expression of miR-130b in lung adenocarcinoma is closely associated with poor prognosis, promoting tumor cell migration and invasion, and serving as a biomarker of unfavorable prognosis for patients. Targeting miR-130b may serve as a potential therapeutic strategy for lung cancer.

LABORATORY INVESTIGATION (2021)

Review Medicine, Research & Experimental

Regulatory role of microRNAs on PTEN signaling

Soudeh Ghafouri-Fard et al.

Summary: PTEN gene encodes a tumor suppressor protein that regulates the PI3K/AKT signaling, and its expression is influenced by various transcription factors and miRNAs, playing key roles in cancer therapy.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Biochemistry & Molecular Biology

miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/RhoA pathway

Jinjin Duan et al.

Summary: The study found that TNS1 is upregulated in NSCLC cells and tissues, and is associated with the prognosis of NSCLC patients. Additionally, TNS1 promotes the growth and metastasis of NSCLC cells via the Akt/mTOR/RhoA pathway. miR-152 targets TNS1 to influence the progression of NSCLC.

BIOSCIENCE REPORTS (2021)

Article Cell Biology

被撤回的出版物: miR-202-3p negatively regulates MMP-1 to inhibit the proliferation, migration and invasion of lung adenocarcinoma cells (Retracted article. See JAN, 2023)

Yong Li et al.

Summary: The study demonstrated the regulation of MMP-1 on proliferation, migration, and invasion of LUAD cells under the control of miR-202-3p, suggesting potential for new therapeutic strategies.

CELL CYCLE (2021)

Review Chemistry, Medicinal

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)

Xin Sun et al.

Summary: EGFR, as a receptor for EGF, is closely related to the inhibition of tumor cell proliferation, invasion, and apoptosis, making it an important anti-tumor target. Small molecule inhibitors targeting EGFR have become crucial biologically active compounds for cancer treatment, especially against NSCLC. Despite significant progress in developing selective EGFR inhibitors, there is still an urgent need for new EGFR inhibitors that are safe, efficient, selective, and low-toxic to avoid adverse pharmacokinetics associated with wild-type EGFR.

EXPERT OPINION ON THERAPEUTIC PATENTS (2021)

Review Biochemistry & Molecular Biology

The Dual Role of Autophagy in Cancer Development and a Therapeutic Strategy for Cancer by Targeting Autophagy

Chul Won Yun et al.

Summary: Autophagy is a cellular degradation process that plays a role in regulating tumorigenesis, metastasis, cancer stem cells, and resistance to anticancer agents. While modulating autophagy may be a promising approach in anticancer therapy, its dual roles present limitations in its application.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

MicroRNA-3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease

Qiankun Lv et al.

Summary: Parkinson's disease is a neurodegenerative disorder characterized by selective loss of dopaminergic neurons. The microRNA miR-3473b has been shown to regulate autophagy and inflammatory factor secretion in PD, indicating a potential therapeutic target for modulating inflammation in Parkinson's disease.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Oncology

miR-139-5p enhances cisplatin sensitivity in non-small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox-B2

Hailian Du et al.

Summary: This study revealed that the lower expression of miR-139-5p in non-small cell lung cancer (NSCLC) tissues can increase cell apoptosis and inhibit proliferation via modulating the PI3K/AKT/caspase-3 signaling pathway, thereby enhancing sensitivity to cisplatin (DDP). Targeting HOXB2 through miR-139-5p could serve as a novel approach to reverse DDP resistance and improve chemosensitivity in NSCLC treatment.

MOLECULAR MEDICINE REPORTS (2021)

Article Multidisciplinary Sciences

Chaperone-mediated autophagy sustains haematopoietic stem-cell function

Shuxian Dong et al.

Summary: Activation of hematopoietic stem cells involves molecular adaptations, with Chaperone-Mediated Autophagy (CMA) playing a role in sustaining HSC function and declining with age. Restoring old HSC functionality through CMA activation suggests it may be a promising therapeutic target for conditions like aging or stem-cell transplantation.

NATURE (2021)

Article Immunology

MicroRNA-142-3p inhibits autophagy and promotes intracellular survival of Mycobacterium tuberculosis by targeting ATG16L1 and ATG4c

Yuliang Qu et al.

Summary: miR-142-3p inhibits M. tuberculosis-induced activation of autophagy, promotes H37Ra survival in macrophages, and exerts its function by targeting ATG16L1 and ATG4c.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Immunology

MicroRNA-106a Inhibits Autophagy Process and Antimicrobial Responses by Targeting ULK1, ATG7, and ATG16L1 During Mycobacterial Infection

Kunmei Liu et al.

Summary: miR-106a acts as a negative regulator in autophagy and antimicrobial effects during M. tuberculosis infection by targeting ULK1, ATG7, and ATG16L1, impacting the survival of the mycobacteria.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

The Role of mTOR Signaling as a Therapeutic Target in Cancer

Nadezhda V. Popova et al.

Summary: This review summarizes the current information on the role of phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling in cancer as a potential target for new therapy options. The mTOR and PI3K/AKT/mTORC1 (mTOR complex 1) signaling pathways are critical for regulating fundamental cell processes, and their deregulation is implicated in cancer, metabolic dysregulation, and aging. The review also discusses recent data on the structure and function of the mTOR pathway, mechanisms of deregulation in human cancers, and the use of PI3K/AKT/mTOR inhibitors in clinical studies for cancer treatment, including issues of resistance and adverse effects.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Nutrition & Dietetics

Targeted deletion of Atg5 in intestinal epithelial cells promotes dextran sodium sulfate-induced colitis

Kyohei Nishino et al.

Summary: This study identified that the autophagy factor AtgS suppresses endoplasmic reticulum stress-induced apoptosis of intestinal epithelial cells by degrading excess p-IRE1 alpha. Lack of AtgS leads to exacerbation of DSS-induced colitis.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2021)

Article Oncology

FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer

Luckson Mathieu et al.

Summary: Atezolizumab and durvalumab, in combination with chemotherapy, have been approved by the FDA for first-line treatment of extensive stage small cell lung cancer, showing improved overall survival in clinical trials. These approvals mark a significant advancement in treatment options for small cell lung cancer patients.

ONCOLOGIST (2021)

Article Medicine, Research & Experimental

miR-4486 reverses cisplatin-resistance of colon cancer cells via targeting ATG7 to inhibiting autophagy

Weiwei Wang et al.

Summary: The study revealed that in colon cancer cells resistant to cisplatin, miR-4486 expression was significantly reduced, and the overexpression of miR-4486 could increase sensitivity to cisplatin by inhibiting autophagy in HCT116/DDP and SW480/DDP cells. Additionally, ATG7 was identified as a target gene of miR-4486, indicating its role in reversing drug resistance.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Oncology

miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer

Bowen Zhu et al.

Summary: The study identified miR-582-5p as a post-transcriptional regulator of the Hippo-YAP/TAZ signaling pathway in NSCLC cells, inhibiting YAP/TAZ signaling by targeting NCKAP1 and PIP5K1C. The findings highlight the potential therapeutic value of restoring miR-582-5p expression in the treatment of lung cancer driven by YAP/TAZ.

CANCERS (2021)

Article Oncology

Tumor Suppressor miR-584-5p Inhibits Migration and Invasion in Smoking Related Non-Small Cell Lung Cancer Cells by Targeting YKT6

Saet Byeol Lee et al.

Summary: Cigarette smoke induces DNA methylation, which downregulates the expression of miR-584-5p in smoking-related lung carcinogenesis. MiR-584-5p suppresses migration and invasion in NSCLC cells by targeting YKT6, and its reduced expression is associated with cancer progression, suggesting it as a potential molecular biomarker for smoking-related NSCLC.

CANCERS (2021)

Article Oncology

The Local Anesthetic Bupivacaine Inhibits the Progression of Non-Small Cell Lung Cancer by Inducing Autophagy Through Akt/mTOR Signaling

Jian-Hua Gu et al.

Summary: The study found that bupivacaine has inhibitory effects on the progression of non-small cell lung cancer (NSCLC) by inducing autophagy. Bupivacaine can reduce tumor cell proliferation, decrease invasion and migration abilities, and inhibit tumor growth through the Akt/mTOR signaling pathway.

FRONTIERS IN ONCOLOGY (2021)

Review Cell Biology

MicroRNAs in the regulation of autophagy and their possible use in age-related macular degeneration therapy

Juha M. T. Hyttinen et al.

Summary: Age-related macular degeneration (AMD) is a progressive disease affecting the vision of elderly individuals. The weakening of autophagy clearance has been suggested as an important mechanism in the pathogenesis of AMD, with autophagy-targeting miRNAs potentially playing a crucial role in AMD therapy.

AGEING RESEARCH REVIEWS (2021)

Article Biochemistry & Molecular Biology

miR-30b-5p inhibits cancer progression and enhances cisplatin sensitivity in lung cancer through targeting LRP8

Haitao Qiu et al.

Summary: It has been demonstrated that miR-30b-5p acts as a tumor suppressor in lung cancer, enhancing the sensitivity of cancer cells to cisplatin, while its association with LRP8 may play a role in affecting its function.

APOPTOSIS (2021)

Article Cell Biology

CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression

Xuan Li et al.

Summary: The E3 ubiquitin ligase CUL3 interacts with BECN1 to promote its ubiquitination and degradation, leading to a decrease in autophagic activity and promoting tumor cell proliferation. Additionally, KLHL38 acts as a substrate adaptor for the CUL3 E3 ligase complex-mediated degradation of BECN1.

AUTOPHAGY (2021)

Article Biochemistry & Molecular Biology

LncRNA MITA1 promotes ge fi tinib resistance by inducing autophagy in lung cancer cells

Jie Hu et al.

Summary: This study uncovered the regulatory role of lncRNA MITA1 in the acquisition of gefitinib resistance in NSCLC, showing that MITA1 can induce autophagy to modulate gefitinib resistance.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Targeting Bcl-2 for cancer therapy

Linlin Zhang et al.

Summary: Apoptosis deficiency is a crucial feature in neoplastic diseases, with the Bcl-2 family of proteins playing a decisive role in regulating apoptosis. Studies have shown that hyperactivation of Bcl-2 anti-apoptotic effects is associated with cancer occurrence and resistance to therapy, making targeting Bcl-2 inactivation a promising route for cancer treatment.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Oncology

microRNA-320b suppresses HNF4G and IGF2BP2 expression to inhibit angiogenesis and tumor growth of lung cancer

Yu-Shui Ma et al.

Summary: miR-320b suppresses lung cancer growth and angiogenesis by inhibiting HNF4G, IGF2BP2 and TK1.

CARCINOGENESIS (2021)

Article Cell Biology

mTOR modulates resistance to gemcitabine in lung cancer in an MTORC2 dependent mechanism

Mahmoud A. Chawsheen et al.

Summary: In this study, targeting the mTOR signaling pathway was found to increase the sensitivity of A549 lung cancer cells to gemcitabine, particularly by inhibiting mTORC2 which induced apoptosis and enhanced the apoptosis-inducing effects of gemcitabine. Results also suggested that Rictor maintains cell survival through modulating multiple signaling pathways, and different cell lines may vary in their sensitivity to mTOR inhibition.

CELLULAR SIGNALLING (2021)

Review Immunology

Envisioning the immune system to determine its role in pancreatic ductal adenocarcinoma: Culprit or victim?

Darya Javadrashid et al.

Summary: Pancreatic ductal adenocarcinoma has a poor 5-year survival rate, and understanding the tumor microenvironment and immunosuppression is crucial for finding better treatment modalities.

IMMUNOLOGY LETTERS (2021)

Article Biochemistry & Molecular Biology

PI3K/Akt/mTOR signaling orchestrates the phenotypic transition and chemo-resistance of small cell lung cancer

Xuefeng Li et al.

Summary: The heterogeneity of SCLC phenotype is associated with different sensitivity to chemotherapy; activation of the PI3K/Akt/mTOR pathway promotes phenotypic transition and chemo-resistance in SCLC cells; combining chemotherapy with PI3K/Akt/mTOR pathway inhibitors can overcome chemo-resistance in SCLC treatment.

JOURNAL OF GENETICS AND GENOMICS (2021)

Review Biochemistry & Molecular Biology

From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy

Afshin Derakhshani et al.

Summary: In the past decade, significant advances have been made in understanding the signaling pathways involved in cancer development, shedding light on potential factors contributing to cancer progression. Single-cell sequencing has revealed genetic instability and intra-tumoral heterogeneity in tumor cells, explaining why current approaches may not be effective in eradicating mutating cancer cells.

MOLECULES (2021)

Article Cell Biology

LncRNA-HOTAIR activates autophagy and promotes the imatinib resistance of gastrointestinal stromal tumor cells through a mechanism involving the miR-130a/ATG2B pathway

Jinyan Zhang et al.

Summary: This study revealed that HOTAIR targets the ATG2B inhibitor miR-130a to upregulate cell autophagy levels, promoting imatinib resistance in GIST cells.

CELL DEATH & DISEASE (2021)

Article Oncology

miR-574-5p mediates epithelial-mesenchymal transition in small cell lung cancer by targeting vimentin via a competitive endogenous RNA network

Yanqin Sun et al.

Summary: The study suggests that HOTTIP may be involved in the EMT of SCLC by binding to miR-574-5p, and that miR-574-5p inhibits VIM expression, a key marker of EMT.

ONCOLOGY LETTERS (2021)

Article Oncology

MicroRNA-217 inhibits the proliferation and invasion, and promotes apoptosis of non-small cell lung cancer cells by targeting sirtuin 1

Guangshun Li et al.

Summary: The study found that miR-217 inhibits the proliferation and invasion of A549 and H1299 cells by targeting SIRT1 and inactivating the SIRT1-mediated AMPK/mTOR signaling pathway, and also induces apoptosis.

ONCOLOGY LETTERS (2021)

Article Oncology

MicroRNA-365b-3p represses the proliferation and promotes the apoptosis of non-small cell lung cancer cells by targeting PPP5C

Xiaomiao Zhang et al.

Summary: The results showed that miR-365b-3p expression was decreased in NSCLC tissues and cell lines. By targeting PPP5C, miR-365b-3p inhibited cell proliferation and induced apoptosis in NSCLC cells.

ONCOLOGY LETTERS (2021)

Article Genetics & Heredity

Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer

Miriam Ragle Aure et al.

Summary: The study reveals the interaction between miRNA expression and DNA methylation in different breast cancer phenotypes, suggesting that miRNAs may impact breast cancer initiation and progression through DNA methylation regulatory pathways.

GENOME MEDICINE (2021)

Article Pharmacology & Pharmacy

Guaiazulene Triggers ROS-Induced Apoptosis and Protective Autophagy in Non-small Cell Lung Cancer

Qin Ye et al.

Summary: The study showed that GYZ can suppress NSCLC by inducing apoptosis through triggering ROS and inhibiting the autophagic pathway in NSCLC cells, which has a cytoprotective effect. Co-administration with an autophagy inhibitor enhances the effectiveness of GYZ, and GYZ acts synergistically with paclitaxel in suppressing NSCLC growth.

FRONTIERS IN PHARMACOLOGY (2021)

Article Oncology

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine

Afshin Derakhshani et al.

Summary: The study revealed an increasing trend of CTLA-4 in colorectal cancer (CRC) and the inhibitory molecule can be suppressed by the chemotherapy drug capecitabine. Inhibiting CTLA-4 can reactivate immune cells against tumors, potentially enhancing treatment outcomes.

CANCERS (2021)

Article Oncology

Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer

Akanksha Khandelwal et al.

Summary: The study found that circulating miR-320a levels were significantly down-regulated in patients with non-small cell lung cancer (NSCLC) and were associated with clinical characteristics such as tumor size, TNM stage, and lymph node metastasis. MiR-320a has a tumor-suppressive role in lung cancer by inhibiting tumor growth and metastasis, with AKT3 signaling pathways being activated in NSCLC due to down-regulated miR-320a levels.

FRONTIERS IN ONCOLOGY (2021)

Article Multidisciplinary Sciences

MiR-326 mediates malignant biological behaviors of lung adenocarcinoma by targeting ZEB1

Mingxin Liu et al.

SCIENCE PROGRESS (2021)

Review Biochemistry & Molecular Biology

Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment

Darya Javadrashid et al.

Summary: Genetic alterations, particularly the K-Ras mutation, play a major role in the progression of pancreatic precursor lesions into PDAC. The tumor microenvironment and immune evasion are challenges in therapeutic approaches, with targeting signaling molecules and immune checkpoint inhibition showing promising results in pancreatic cancer treatment.

BIOMEDICINES (2021)

Article Immunology

Autophagy receptor CCDC50 tunes the STING-mediated interferon response in viral infections and autoimmune diseases

Panpan Hou et al.

Summary: CCDC50, a newly identified autophagy receptor, plays a critical role in regulating STING-directed type I IFN signaling and immune response. Deficiency in CCDC50 may lead to overactivation of immune responses in SLE patients and enhanced immune response in HSV-1 infections.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Autophagy in major human diseases

Daniel J. Klionsky et al.

Summary: Autophagy is crucial for maintaining cellular and organismal homeostasis, and dysfunction in autophagy is implicated in the pathogenesis of major human disorders across various organ systems.

EMBO JOURNAL (2021)

Article Biochemistry & Molecular Biology

miR-1 Targeted Downregulation of Bcl-2 Increases Chemosensitivity of Lung Cancer Cells

Cuimei Chen et al.

Summary: Bcl-2 is upregulated in lung cancer cells, negatively correlated with patient prognosis, while miR-1 affects the chemosensitivity of lung cancer cells by targeting Bcl-2.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2021)

Article Medicine, Research & Experimental

miR-30a-5p mitigates autophagy by regulating the Beclin-1/ATG16 pathway in renal ischemia/reperfusion injury

Ye Fang et al.

Summary: The study demonstrated that miR-30a-5p expression levels were significantly decreased in renal I/R injury, suggesting a potential role in mitigating autophagy by regulating the Beclin-1/ATG16 pathway.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Article Medical Laboratory Technology

MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5

Qing Li et al.

Summary: The study revealed that miR-133a-3p was significantly downregulated in gefitinib-resistant NSCLC cells, and overexpression of miR-133a-3p could increase the sensitivity of cells to gefitinib. SPAG5 was identified as an important target gene of miR-133a-3p, which could reverse the miR-133a-3p-mediated gefitinib sensitivity.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Article Oncology

Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy

Ebru Guclu et al.

Summary: Silencing lncRNA HIF1A-AS2 increased drug sensitivity and decreased autophagy in SCLC cells. Knockdown of HIF1A-AS2 affected the expression of genes related to drug resistance and autophagy, such as MRP1, HIF-1 alpha, and Beclin-1. The hypoxia-HIF1A-AS2-autophagy interaction was considered crucial in determining drug sensitivity in these cells.

MEDICAL ONCOLOGY (2021)

Article Oncology

miR221 regulates TGF-β1-induced HSC activation through inhibiting autophagy by directly targeting LAMP2

Ran Cheng et al.

Summary: The study indicates that miR221 may regulate TGF-beta 1-induced HSC activation by inhibiting autolysosome function through direct targeting of LAMP2. The molecular mechanism of miR221 in regulating TGF-beta 1-induced HSC activation may provide novel insights into therapies to ameliorate the pathological progression of liver fibrosis.

MOLECULAR MEDICINE REPORTS (2021)

Review Biochemistry & Molecular Biology

Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products

Iksen et al.

Summary: Lung cancer is a common and highly lethal cancer, posing a major clinical challenge. The PI3K/AKT/mTOR pathway has been linked to lung cancer, making it a significant therapeutic target. Interest in targeting these pathways with medications has grown, showing promise in various types of studies.

MOLECULES (2021)

Review Endocrinology & Metabolism

Autophagy in metabolic disease and ageing

Munehiro Kitada et al.

Summary: Dysfunctional autophagy can lead to various diseases, particularly age-related metabolic derangements such as insulin resistance, type 2 diabetes mellitus, and sarcopenic obesity. The decline in autophagic efficiency with age and the interference of overnutrition can exacerbate these conditions by accumulating damaged cellular components. Developing autophagy-based therapies may hold potential in treating metabolic diseases associated with aging.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Article Oncology

Autophagy inhibition and microRNA-199a-5p upregulation in paclitaxel-resistant A549/T lung cancer cells

Tianjiao Zeng et al.

Summary: The study found that miR-199a-5p was upregulated in MDR lung cancer cells, inhibiting autophagy and increasing resistance to multiple chemotherapeutic drugs. Mechanistically, miR-199a-5p blocked autophagy by activating the PI3K/Akt/mTOR signaling pathway, inhibiting autophagy-related protein expression, and targeting p62 protein. This discovery may offer novel insights for future multidrug-resistant lung cancer chemotherapy.

ONCOLOGY REPORTS (2021)

Article Pathology

miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8

Chunxiu Hu et al.

Summary: The study revealed that CDCA8 was overexpressed in LUAD tissues while its upstream miRNA miR-133b was downregulated, and miR-133b could inhibit the proliferation, invasion, and migration of LUAD cells by targeting CDCA8.

PATHOLOGY RESEARCH AND PRACTICE (2021)

Article Multidisciplinary Sciences

Selenium inhibits growth of trastuzumab-resistant human breast cancer cells via downregulation of Akt and beclin-1

Joohyun Woo et al.

Summary: The study investigated the effect of selenium on HER2-positive breast cancer cells in response to trastuzumab, showing that the combination of selenium and trastuzumab had an antitumor effect in trastuzumab-resistant breast cancer cells by downregulating phosphorylated Akt and beclin1-related autophagy.

PLOS ONE (2021)

Article Oncology

MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1

Mengning Xia et al.

Summary: MiR-194-5p enhances the sensitivity of NSCLC cells to DOX by directly inhibiting HIF-1, providing insights into potential treatments for drug-resistant NSCLC.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)

Review Immunology

Role of chaperone-mediated autophagy in the pathophysiology including pulmonary disorders

Yusuke Hosaka et al.

Summary: CMA is a form of autophagy characterized by the selective degradation of proteins, playing crucial roles in various organs and diseases, including cancer and pulmonary disorders. Understanding the CMA mechanism may lead to new treatment modalities for refractory disorders.

INFLAMMATION AND REGENERATION (2021)

Article Oncology

miR-342-3p Regulates the Proliferation and Apoptosis of NSCLC Cells by Targeting BCL-2

Zhongjie Chen et al.

Summary: The study revealed that microRNA-342-3p is downregulated in nonsmall cell lung cancer compared to normal cells and tissues. Overexpression of microRNA-342-3p suppressed cell proliferation and promoted apoptosis by repressing the expression of B-cell lymphoma-2, suggesting it as a potential target for nonsmall cell lung cancer treatment.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)

Article Biotechnology & Applied Microbiology

MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route

Butong Sun et al.

Summary: The research found that miR-25-3p plays a crucial role in cisplatin resistance in NSCLC, accelerating drug tolerance by regulating the PTEN/PI3K/AKT signaling pathway.

BIOENGINEERED (2021)

Article Oncology

MiR-30a sensitized lung cancer against neoadjuvant chemotherapy by depressing autophagy

Xiao Lin et al.

Summary: The study found that the low expression of miR-30a was closely related to malignant pathological characteristics and prognosis in NSCLC patients after neoadjuvant chemotherapy. Up-regulation of miR-30a can reduce the resistance of NSCLC cells to chemotherapy drugs, suppress chemotherapy-induced autophagy, and promote cell apoptosis.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

MicroRNA-32-5p inhibits epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting SMAD family 3

Jin-Xing Zhang et al.

Summary: The study found that miR-32-5p is downregulated in NSCLC tissues and inhibits the migration and invasion abilities of tumors by targeting SMAD3. miR-32-5p may be a potential therapeutic target for the treatment of lung adenocarcinoma.

JOURNAL OF CANCER (2021)

Article Oncology

Overexpression of microRNA-124-5p sensitizes non-small cell lung cancer cells to treatment with 5-fluorouracil via AEG-1 regulation

Xiaoxia Tan et al.

Summary: The study revealed that miR-124-5p may regulate the chemotherapeutic sensitivity of NSCLC cells by reducing AEG-1 expression, indicating its potential as a promising biomarker or therapeutic target for patients with NSCLC.

ONCOLOGY LETTERS (2021)

Article Oncology

Expression profile and diagnostic value of circRNAs in peripheral blood from patients with systemic lupus erythematosus

Qing Luo et al.

Summary: The study identified dysregulated circRNAs in peripheral blood of patients with SLE, with hsa_circ_0082688-hsa_circ_0082689 combination showing potential diagnostic value.

MOLECULAR MEDICINE REPORTS (2021)

Article Cell Biology

MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway

Junlei Han et al.

Summary: miR-20a suppresses NSCLC growth by inhibiting the RRM2-mediated PI3K/Akt signaling pathway, serving as a potential tumor suppressor and molecular target for NSCLC treatment.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)

Review Biochemistry & Molecular Biology

History of the Selective Autophagy Research: How Did It Begin and Where Does It Stand Today?

Vladimir Kirkin

JOURNAL OF MOLECULAR BIOLOGY (2020)

Review Immunology

The Controversial Role of Autophagy in Tumor Development: A Systematic Review

Bridilla Luiza Colhado Rodrigues et al.

IMMUNOLOGICAL INVESTIGATIONS (2020)

Review Biochemistry & Molecular Biology

Autophagosome-Lysosome Fusion

Peter Lorincz et al.

JOURNAL OF MOLECULAR BIOLOGY (2020)

Review Pharmacology & Pharmacy

Drug resistance to targeted therapeutic strategies in non-small cell lung cancer

Wen-juan Liu et al.

PHARMACOLOGY & THERAPEUTICS (2020)

Review Oncology

At a glance: A history of autophagy and cancer

Xin Wen et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Medicine, Research & Experimental

MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7

Lili Lou et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Biochemistry & Molecular Biology

Autophagy and microbial pathogenesis

Matthew D. Keller et al.

CELL DEATH AND DIFFERENTIATION (2020)

Article Biochemistry & Molecular Biology

Ganoderic acid DM induces autophagic apoptosis in non-small cell lung cancer cells by inhibiting the PI3K/Akt/mTOR activity

Junbo Xia et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2020)

Article Medicine, Research & Experimental

miR-373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1

Pin Lv et al.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)

Review Biochemistry & Molecular Biology

Autophagy and autophagy-related proteins in cancer

Xiaohua Li et al.

MOLECULAR CANCER (2020)

Review Oncology

Immunotherapeutic approaches for small-cell lung cancer

Wade T. Iams et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers

Omid Kooshkaki et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cell Biology

Manipulation of selective macroautophagy by pathogens at a glance

Yingying Cong et al.

JOURNAL OF CELL SCIENCE (2020)

Article Biotechnology & Applied Microbiology

Long Non-Coding RNA NNT-AS1 Contributes to Cisplatin Resistance via miR-1236-3p/ATG7 Axis in Lung Cancer Cells

Haifeng Wang et al.

ONCOTARGETS AND THERAPY (2020)

Article Oncology

Upregulation of microRNA-1 inhibits proliferation and metastasis of breast cancer

Jing Peng et al.

MOLECULAR MEDICINE REPORTS (2020)

Review Oncology

Autophagy Regulation by the Translation Machinery and Its Implications in Cancer

Pilar Sarah Acevo-Rodriguez et al.

FRONTIERS IN ONCOLOGY (2020)

Review Pharmacology & Pharmacy

Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment

Priyanka Sharma et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers

Omid Kooshkaki et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Cell Biology

Autophagy-mediating microRNAs in cancer chemoresistance

Yuanming Jing et al.

CELL BIOLOGY AND TOXICOLOGY (2020)

Review Oncology

Autophagy-related MicroRNAs in chronic lung diseases and lung cancer

Samaneh Rezaei et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

Review Pharmacology & Pharmacy

MicroRNAs as mediators of drug resistance mechanisms

Andrea Lampis et al.

CURRENT OPINION IN PHARMACOLOGY (2020)

Review Cell Biology

Microautophagy - distinct molecular mechanisms handle cargoes of many sizes

Sebastian Schuck

JOURNAL OF CELL SCIENCE (2020)

Article Oncology

Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer

Shuangshuang Mao et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

MicroRNAs involved in drug resistance of breast cancer by regulating autophagy

Nan Wen et al.

JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2020)

Article Biochemistry & Molecular Biology

Novel, abundant Drosha isoforms are deficient in miRNA processing in cancer cells

Lisheng Dai et al.

RNA BIOLOGY (2020)

Review Oncology

The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity

Rodolfo Chavez-Dominguez et al.

FRONTIERS IN ONCOLOGY (2020)

Review Cell Biology

The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?

Jing-Li Xu et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Oncology

Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy

Daolu Yuwen et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)

Article Biochemistry & Molecular Biology

High expression of miR-510 was associated with CGG expansion located at upstream of FMR1 into full mutation

Zahra Fazeli et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Medicine, Research & Experimental

MicroRNA-145 replacement effect on growth and migration inhibition in lung cancer cell line

Navaz Sadeghiyeh et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Cell Biology

Phosphorylation of Syntaxin 17 by TBK1 Controls Autophagy Initiation

Suresh Kumar et al.

DEVELOPMENTAL CELL (2019)

Review Oncology

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

Lu Zhang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Oncology

The role and mechanisms of action of microRNAs in cancer drug resistance

Wengong Si et al.

CLINICAL EPIGENETICS (2019)

Article Medicine, Research & Experimental

miR-150-5p Inhibits Non-Small-Cell Lung Cancer Metastasis and Recurrence by Targeting HMGA2 and β-Catenin Signaling

Fu-Qiang Dai et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Article Biochemistry & Molecular Biology

MiR-207 inhibits autophagy and promotes apoptosis of cardiomyocytes by directly targeting LAMP2 in type 2 diabetic cardiomyopathy

Ruinan Xing et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Oncology

Cancer Progress and Priorities: Lung Cancer

Matthew B. Schabath et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)

Review Immunology

LC3-associated phagocytosis: host defense and microbial response

Sandeep Upadhyay et al.

CURRENT OPINION IN IMMUNOLOGY (2019)

Review Cell Biology

EMT Transition States during Tumor Progression and Metastasis

Ievgenia Pastushenko et al.

TRENDS IN CELL BIOLOGY (2019)

Review Pharmacology & Pharmacy

MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential

Hannah Petrek et al.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)

Article Biochemistry & Molecular Biology

DNA methylation regulated microRNAs in human cervical cancer

Vinay K. Varghese et al.

MOLECULAR CARCINOGENESIS (2018)

Review Oncology

Lung cancer epigenetics: From knowledge to applications

Michael Duruisseaux et al.

SEMINARS IN CANCER BIOLOGY (2018)

Article Medicine, General & Internal

miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2

Hui-Ning Liu et al.

ARCHIVES OF MEDICAL SCIENCE (2018)

Article Cell Biology

MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR

Hang Yin et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Review Oncology

MicroRNA Key to Angiogenesis Regulation: miRNA Biology and Therapy

Ankit Tiwari et al.

CURRENT CANCER DRUG TARGETS (2018)

Review Biochemistry & Molecular Biology

MicroRNAs associated with therapy of non-small cell lung cancer

Junmi Lu et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)

Article Cell Biology

The miR-3127-5p/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer

Dongfang Tang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

Article Agriculture, Dairy & Animal Science

miR-26a suppresses autophagy in swine Sertoli cells by targeting ULK2

M. Ran et al.

REPRODUCTION IN DOMESTIC ANIMALS (2018)

Review Multidisciplinary Sciences

The biology and management of non-small cell lung cancer

Roy S. Herbst et al.

NATURE (2018)

Review Medicine, General & Internal

Lung cancer: current therapies and new targeted treatments

Fred R. Hirsch et al.

LANCET (2017)

Review Biotechnology & Applied Microbiology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rajesha Rupaimoole et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Biotechnology & Applied Microbiology

MiR-9 enhances the sensitivity of A549 cells to cisplatin by inhibiting autophagy

Yan Zhang et al.

BIOTECHNOLOGY LETTERS (2017)

Article Cell Biology

MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMG B1-Mediated Autophagy

Yuqing Chen et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Review Biochemistry & Molecular Biology

mTOR Signaling in Growth, Metabolism, and Disease

Robert A. Saxton et al.

Article Biochemistry & Molecular Biology

miR-487b-5p Regulates Temozolomide Resistance of Lung Cancer Cells Through LAMP2-Medicated Autophagy

Liang Bao et al.

DNA AND CELL BIOLOGY (2016)

Article Peripheral Vascular Disease

Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer

Guangmei Mao et al.

ANGIOGENESIS (2015)

Article Multidisciplinary Sciences

Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells

Hui-Mei Wu et al.

SCIENTIFIC REPORTS (2015)

Article Multidisciplinary Sciences

A dual role for autophagy in a murine model of lung cancer

Shuan Rao et al.

NATURE COMMUNICATIONS (2014)

Review Medicine, General & Internal

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

Tiago B. de Castria et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)